(Reuters) – U.S. regulators are to fast-track the review of a new use of AstraZeneca’s heart drug Brilinta, meaning it could get the green light in the third quarter to be given to patients with a history of heart attacks. The drugmaker said on Wednesday the decision by the Food and Drug Administration (FDA) reflected […]

CAMBRDIGE, Mass. – Celgene Corporation (CELG) has struck two deals with other pharmaceutical companies with a combined value of $110 million to advance its oncology platform, continuing the cancer drugmaking company’s deal making trend to advance its oncology pipeline. Today Celgene announced it entered into an $80 million agreement with Agios Pharmaceuticals (AGIO) to develop […]

Malaria tests are seen on a table in the Ta Gay Laung village hall in Hpa-An district in Kayin state, south-eastern Myanmar, November 28, 2014. Reuters/Astrid Zweynert LONDON (Thomson Reuters Foundation) – Mosquitoes are rapidly developing resistance to insecticides used in bed nets that millions of people rely on to protect them from malaria, experts […]

[embedded content] According to the results of a new study, teens were able to purchase potentially dangerous supplements at a variety of health food stores across the US, despite labels reading “for adult use only.” More troubling is the fact that the staff at certain stores recommended and endorsed specific products, although they were “for […]

VANCOUVER, BC–(Marketwired – April 29, 2015) – Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSX VENTURE: APC) (FRANKFURT: 0E8) is pleased to announce that its current lead compound APC 101 successfully diminished the frequency of tumor metastasis in the 4T1 animal model. The Company’s academic collaborators used three different methods, carried out over several […]

THOUSAND OAKS, Calif., April 29, 2015 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the U.S. Food and Drug Administration (FDA) will review data supporting the Company’s Biologics License Application (BLA) for RepathaTM (evolocumab) for the treatment of high cholesterol at a meeting on June 10, 2015. Repatha […]

• VesselNavigator has been designed for use in conjunction with Philips interventional X-ray systems to guide catheters during treatment of vascular disease. • Major reduction of contrast medium (70%) demonstrated in clinical study, enabling minimally invasive treatment of aortic aneurysms in the fast growing number of patients currently unable to benefit from minimally-invasive techniques. Amsterdam, […]

MOUNTAIN VIEW, Calif., April 29, 2015 /PRNewswire/ — Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced two management promotions.  Dr. Edwin S. Kamemoto has been promoted to the newly created position of Executive Vice President, R&D and Quality.  In this new role,  Dr. Kamemoto will be responsible for research and development, regulatory affairs, clinical research, pharmacovigilance, and the […]

Once again, after decades of common use, a frequently implanted device has been found to confer no benefit whatsoever over a much less invasive therapy. Cardiologists and radiologists often implant the device, called a retrievable inferior vena cava filter, inside people who are at high risk for developing potentially lethal blood clots. The filter is designed to prevent […]

WASHINGTON–(BUSINESS WIRE)–The Biotechnology Industry Organization (BIO) today releases the following statement on the 21st Century Cures Initiative discussion draft shared by Chairman Fred Upton (R-MI), Rep. Diana DeGette (D-CO), Rep. Frank Pallone, Jr. (D-NJ), Rep. Joe Pitts (R-PA), and Rep. Gene Green (D-TX). This statement can be attributed to Jim Greenwood, BIO President and CEO: […]